Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Pulmonology (Drugs, Pharmaceuticals, Biotechnology & Biosimilars)

Amira Pharmaceuticals

Attachments

2011: Bristol-Myers Acquires Amira Pharmaceuticals for $325 Million, Scoops Up Lung Drug (2011)
Amira Cuts Half of Staff, Scientific Founders Exit as Company Seeks to Conserve Cash(2010)
Amira Pharmaceuticals is creating anti-inflammatory agents.
Amira’s last venture round, worth $25 million, came from Novo A/S, Avalon Ventures, Prospect Venture Partners, and Versant Ventures back in March 2007
Founded 2005
San Diego, California
The Company’s Lead Drug Candidate for Lung Fibrosis Just Entered Its First Clinical Trial Last Month, Meaning It Has Several Hurdles Left to Clear before It Can Generate the Kind of Value that Will Prompt Venture Investors or Prospective Partners to Shell